EULAR 2023 recommendations for the treatment of systemic sclerosis
																	
									Authors:
											M. Olejárová; 											M. Tomčík										
				
									Authors‘ workplace:
											Revmatologický ústav, Revmatologická klinika 1. LF UK, Praha
																
				
									Published in:
					Čes. Revmatol., 32, 2024, No. 4, p. 162-165.
					
				
									Category:
					Úvodník
					
				
							
Sources
Del Galdo F, Lescoat A, Conaghan PG, Bertoldo E, Čolić J, Santiago T, et al. EULAR recommendations for the treatment of systemic sclerosis: 2023 update. Ann Rheum Dis. 2024 Oct 17:ard-2024-226430. Epub ahead of print. PMID: 39393843.
Labels
Dermatology & STDs Paediatric rheumatology RheumatologyArticle was published in
Czech Rheumatology
 
					2024 Issue 4
Most read in this issue
- VEXAS syndrome: a rare and severe autoinflammatory disease
- EULAR 2023 recommendations for the treatment of systemic sclerosis
- Rheumatoid arthritis and mental health: Czech clinical data
- Position statement of the Czech Society of Rheumatology on remote care and telemedicine